|
Index of reports
> Cases resulting in hospitalization (49)
> Cases with Dyspnoea (5)
Below is the selection of adverse event reports related to Ranitidine that includes cases resulting in hospitalization where reactions include dyspnoea.
Adverse event in 39 year old female receiving Ranitidine
Reported by a consumer/non-health professional from Spain on 2007-06-29
Patient: 39 year old female
Adverse reactions / side effects: Dyspnoea, Dysphagia, Chest Pain
Adverse event resulted in: hospitalization
Suspect drug(s):
Taxol
Indication: Neoplasm Malignant
Start date: 2006-05-10
End date: 2006-05-10
Cisplatin
Indication: Neoplasm Malignant
Start date: 2006-05-10
End date: 2006-05-10
Ranitidine
Indication: Neoplasm Malignant
Start date: 2006-05-10
End date: 2006-05-10
Adverse event in 75 year old female receiving Ranitidine
Reported by a individual with unspecified qualification from France on 2007-02-15
Patient: 75 year old female, weighing 110.0 kg (242.0 pounds)
Adverse reactions / side effects: Arrhythmia Supraventricular, Dyspnoea, Tongue Disorder, Macroglossia, Atrial Fibrillation, Laryngeal Oedema, Infection
Adverse event resulted in: hospitalization
Suspect drug(s):
Allopurinol Sodium
Dosage: 1 df, qd
Administration route: Oral
End date: 2006-10-30
Bipreterax
Dosage: 1 df, qd
Administration route: Oral
Start date: 2005-09-01
End date: 2006-10-30
Ranitidine
Dosage: 50 mg per day
Administration route: Oral
End date: 2006-10-30
Triatec
Dosage: 5 mg, qd
Administration route: Oral
Acarbose
Dosage: 50 mg, qd
Administration route: Oral
Tareg
Dosage: 80 mg, qd
Administration route: Oral
End date: 2006-10-30
Other drugs received by patient: Lasix; Diamicron; Aspegic 1000
Adverse event in receiving Ranitidine
Reported by a consumer/non-health professional from United States on 2007-02-13
Patient:
Adverse reactions / side effects: Atrial Tachycardia, Dyspnoea, Tongue Oedema, Atrial Fibrillation, Laryngeal Oedema
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 5 mg, qd
Administration route: Oral
End date: 2006-10-30
Altace
Start date: 2006-11-01
Acarbose
Dosage: 50 mg, qd
Administration route: Oral
End date: 2006-10-30
Allopurinol Sodium
Dosage: 1 u, qd
Administration route: Oral
End date: 2006-10-30
Tareg
Dosage: 80 mg, qd
Administration route: Oral
End date: 2006-10-30
Bipreterax
Dosage: 1 u, qd
Start date: 2005-09-01
End date: 2006-10-30
Ranitidine
Dosage: 50 mg, qd
Administration route: Oral
End date: 2006-10-30
Other drugs received by patient: Lasilix / 00032601 /; Diamicron; Aspegic / 00657701 /
Adverse event in 75 year old female receiving Ranitidine
Reported by a physician from France on 2007-01-30
Patient: 75 year old female, weighing 110.0 kg (242.0 pounds)
Adverse reactions / side effects: Dyspnoea, Allergic Oedema, Tongue Oedema, Atrial Fibrillation, Laryngeal Oedema, Infection
Adverse event resulted in: hospitalization
Suspect drug(s):
Acarbose
Dosage: total daily dose: 50 mg unit dose: 50 mg
Administration route: Oral
Indication: Diabetes Mellitus
Allopurinol Sodium
Administration route: Oral
Indication: Hyperuricaemia
End date: 2006-10-30
Tareg
Administration route: Oral
Indication: Hypertension
End date: 2006-10-30
Bipreterax
Administration route: Oral
Indication: Hypertension
Start date: 2005-09-01
End date: 2006-10-30
Ranitidine
Administration route: Oral
Indication: Unevaluable Event
End date: 2006-10-30
Triatec
Dosage: total daily dose: 5 mg unit dose: 5 mg
Administration route: Oral
Indication: Hypertension
Other drugs received by patient: Lasix; Diamicron; Aspegic 1000
Adverse event in 75 year old female receiving Ranitidine
Reported by a physician from France on 2007-01-17
Patient: 75 year old female, weighing 110.0 kg (242.0 pounds)
Adverse reactions / side effects: Dyspnoea, Allergic Oedema, Tongue Oedema, Laryngeal Oedema
Adverse event resulted in: hospitalization
Suspect drug(s):
Acarbose
Dosage: total daily dose: 50 mg unit dose: 50 mg
Administration route: Oral
Indication: Diabetes Mellitus
Allopurinol Sodium
Administration route: Oral
Indication: Hyperuricaemia
Tareg
Administration route: Oral
Indication: Hypertension
Bipreterax
Administration route: Oral
Indication: Hypertension
Start date: 2005-09-01
Ranitidine
Administration route: Oral
Indication: Unevaluable Event
Triatec
Dosage: total daily dose: 5 mg unit dose: 5 mg
Administration route: Oral
Indication: Hypertension
Other drugs received by patient: Lasix; Diamicron; Aspegic 1000
|
